Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek Tang

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Clinical Therapeutics|April 4, 2018
Progression-free Survival With First-line Endocrine-based Therapies Among Postmenopausal Women With HR+/HER2- Metastatic Breast Cancer:: A Network Meta-analysisRajeev Ayyagari, Derek Tang, Oscar Patterson-Lomba, et al.
Clinical Genitourinary Cancer|November 16, 2019
Real-world Clinical Outcomes of Pazopanib Immediately After Discontinuation of Immunotherapy for Advanced Renal Cell CarcinomaXiting Cao, Derek Tang, Barbara Ratto, et al.
Current Medical Research and Opinion|May 22, 2018
Progression-free survival with endocrine-based therapies following progression on non-steroidal aromatase inhibitor among postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative metastatic breast cancer: a network meta-analysisRajeev Ayyagari, Derek Tang, Oscar Patterson-Lomba, et al.
Pharmacoeconomics|December 6, 2024
Value of Innovative Multiple Myeloma Treatments from Patient and Healthcare Provider Perspectives: Evidence from a Discrete Choice ExperimentSakil Syeed, Chia Jie Tan, Amandeep Godara, et al.
Future Oncology (London, England)|April 7, 2022
Real-world clinical outcomes of patients with myelofibrosis treated with ruxolitinib: a medical record reviewFrancesco Passamonti, Florian H Heidel, Rohan C Parikh, et al.
Journal of Clinical Medicine|February 15, 2022
A Systematic Literature Review of the Relationship between Serum Ferritin and Outcomes in Myelodysplastic SyndromesEsther Natalie Oliva, Krystal Huey, Sohan Deshpande, et al.
Gastrointestinal Endoscopy|October 14, 2023
Performance of capsule endoscopy for the detection of small intestinal neuroendocrine tumors in familial carcinoid: a prospective single-site studyDerek Tang, Ramona Lim, Louis Korman, et al.
Arthritis Care & Research|June 9, 2016
Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid ArthritisBrian C Sauer, Chia-Chen Teng, Derek Tang, et al.
Gastroenterology|March 23, 2016
Polyclonal Crypt Genesis and Development of Familial Small Intestinal Neuroendocrine TumorsYoshitatsu Sei, Jianying Feng, Xilin Zhao, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 17, 2022
Impact of Lenalidomide Treatment on Overall Survival in Patients With Lower-Risk, Transfusion-Dependent Myelodysplastic SyndromesValeria Santini, Aristoteles Giagounidis, Christopher G Pelligra, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Clinical Therapeutics|April 4, 2018
Progression-free Survival With First-line Endocrine-based Therapies Among Postmenopausal Women With HR+/HER2- Metastatic Breast Cancer:: A Network Meta-analysisRajeev Ayyagari, Derek Tang, Oscar Patterson-Lomba, et al.
Clinical Genitourinary Cancer|November 16, 2019
Real-world Clinical Outcomes of Pazopanib Immediately After Discontinuation of Immunotherapy for Advanced Renal Cell CarcinomaXiting Cao, Derek Tang, Barbara Ratto, et al.
Current Medical Research and Opinion|May 22, 2018
Progression-free survival with endocrine-based therapies following progression on non-steroidal aromatase inhibitor among postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative metastatic breast cancer: a network meta-analysisRajeev Ayyagari, Derek Tang, Oscar Patterson-Lomba, et al.
Pharmacoeconomics|December 6, 2024
Value of Innovative Multiple Myeloma Treatments from Patient and Healthcare Provider Perspectives: Evidence from a Discrete Choice ExperimentSakil Syeed, Chia Jie Tan, Amandeep Godara, et al.
Future Oncology (London, England)|April 7, 2022
Real-world clinical outcomes of patients with myelofibrosis treated with ruxolitinib: a medical record reviewFrancesco Passamonti, Florian H Heidel, Rohan C Parikh, et al.
Journal of Clinical Medicine|February 15, 2022
A Systematic Literature Review of the Relationship between Serum Ferritin and Outcomes in Myelodysplastic SyndromesEsther Natalie Oliva, Krystal Huey, Sohan Deshpande, et al.
Gastrointestinal Endoscopy|October 14, 2023
Performance of capsule endoscopy for the detection of small intestinal neuroendocrine tumors in familial carcinoid: a prospective single-site studyDerek Tang, Ramona Lim, Louis Korman, et al.
Arthritis Care & Research|June 9, 2016
Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid ArthritisBrian C Sauer, Chia-Chen Teng, Derek Tang, et al.
Gastroenterology|March 23, 2016
Polyclonal Crypt Genesis and Development of Familial Small Intestinal Neuroendocrine TumorsYoshitatsu Sei, Jianying Feng, Xilin Zhao, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 17, 2022
Impact of Lenalidomide Treatment on Overall Survival in Patients With Lower-Risk, Transfusion-Dependent Myelodysplastic SyndromesValeria Santini, Aristoteles Giagounidis, Christopher G Pelligra, et al.
Pageof 4